Assyro AI

Orange Book product · Brand (NDA)

NOURIANZ

ISTRADEFYLLINE

Brand (NDA)NDA 022075RX KYOWA KIRIN

At a glance

Aug 27, 2019

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 27, 2019

    6 yr 11 mo ago

  2. Today

  3. Patent 8318201 expires

    Listed drug product patent expiration.

    Sep 05, 2027

    in 1 yr 3 mo

  4. Patent 7727993 expires

    Listed drug product patent expiration.

    Jan 28, 2028

    in 1 yr 8 mo

Pharmaceutical detail

Active ingredient

ISTRADEFYLLINE

Strength

20MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 022075

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8318201Sep 05, 2027in 1 yr 3 mo
Product
7727993Jan 28, 2028in 1 yr 8 mo
ProductU-2623
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.